SG11201804542YA - Steviol glycoside compositions for oral ingestion or use - Google Patents
Steviol glycoside compositions for oral ingestion or useInfo
- Publication number
- SG11201804542YA SG11201804542YA SG11201804542YA SG11201804542YA SG11201804542YA SG 11201804542Y A SG11201804542Y A SG 11201804542YA SG 11201804542Y A SG11201804542Y A SG 11201804542YA SG 11201804542Y A SG11201804542Y A SG 11201804542YA SG 11201804542Y A SG11201804542Y A SG 11201804542YA
- Authority
- SG
- Singapore
- Prior art keywords
- international
- minnesota
- compositions
- pct
- publication
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 7
- 239000004383 Steviol glycoside Substances 0.000 title abstract 4
- 235000019411 steviol glycoside Nutrition 0.000 title abstract 4
- 229930182488 steviol glycoside Natural products 0.000 title abstract 4
- 150000008144 steviol glycosides Chemical class 0.000 title abstract 4
- 235000019202 steviosides Nutrition 0.000 title abstract 4
- 230000037406 food intake Effects 0.000 title abstract 2
- 102220547770 Inducible T-cell costimulator_A23L_mutation Human genes 0.000 abstract 2
- 239000003795 chemical substances by application Substances 0.000 abstract 2
- 235000003599 food sweetener Nutrition 0.000 abstract 2
- 229920000728 polyester Polymers 0.000 abstract 2
- 239000003765 sweetening agent Substances 0.000 abstract 2
- 241000422980 Marietta Species 0.000 abstract 1
- 235000013361 beverage Nutrition 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 239000002417 nutraceutical Substances 0.000 abstract 1
- 235000021436 nutraceutical agent Nutrition 0.000 abstract 1
- 230000008520 organization Effects 0.000 abstract 1
- 239000000047 product Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/30—Artificial sweetening agents
- A23L27/33—Artificial sweetening agents containing sugars or derivatives
- A23L27/36—Terpene glycosides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
- A23L2/60—Sweeteners
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/20—Carbocyclic rings
- C07H15/24—Condensed ring systems having three or more rings
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/24—Non-sugar sweeteners
- A23V2250/262—Stevioside
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/20—Carbocyclic rings
- C07H15/24—Condensed ring systems having three or more rings
- C07H15/256—Polyterpene radicals
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Seasonings (AREA)
- Non-Alcoholic Beverages (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
- Saccharide Compounds (AREA)
Abstract
INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property -' Organization International Bureau (43) International Publication Date .... ....r .„,„1 8 June 2017 (08.06.2017) W I P0 1 PCT ID Hit (10) WO 111111111111111111IIIIIIII International II 2017/095932 III 11111101 Publication IIIIIIIIII III IIII Number Al RIO IIII IIIIIIII (51) International Patent Classification: (81) Designated States (unless otherwise indicated, for every A23L 27/30 (2016.01) A23L 2/60 (2006.01) kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, (21) International Application Number: BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, PCT/US2016/064227 DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, (22) International Filing Date: HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, 30 November 2016 (30.11.2016) KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, (25) Filing Language: English OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, (26) Publication Language: English SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, (30) Priority Data: ZW. 62/260,942 30 November 2015 (30.11.2015) US 62/351,674 17 June 2016 (17.06.2016) US (84) Designated States (unless otherwise indicated, for every kind of regional protection available): ARIPO (BW, GH, (71) Applicant: CARGILL, INCORPORATED [US/US]; GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, 15407 McGinty Road West, Wayzata, Minnesota 55391 TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, (US). TJ, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, (72) Inventors: CARLSON, Ting Liu; 55 Lakes Edge Way, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, Marietta, South Carolina 29661 (US). GASPARD, Dan S.; LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, 2550 Heron Lane, Victoria, Minnesota 55386 (US). GU- GW, KM, ML, MR, NE, SN, TD, TG). THRIE, Brian D.; 8123 Stone Creek Drive, Chanhassen, Minnesota 55317 (US). MORTENSON, Michael Alan; Published: 23750 Sarah Circle, Rogers, Minnesota 55374 (US). 21(3)) — with international search report (Art (74) Agent: WARMINSKY, Joshua M.; Cargill, Incorporated, 15407 McGinty Road West, MS24, Wayzata, Minnesota 55391 (US). 1-1 .4t ei M ct\ in ct\ O N 1-1 (54) Title: STEVIOL GLYCOSIDE COMPOSITIONS FOR ORAL INGESTION OR USE 0 ei (57) : The present disclosure relates to compositions including a plurality of steviol glycosides. The present disclosure also es ) relates to sweetener compositions and sweetened compositions including a combination of steviol glycosides, and uses of such ,„I f sweetener compositions to prepare sweetened compositions including food, beverages, dental products, pharmaceuticals, nutraceut - icals, and the like.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562260942P | 2015-11-30 | 2015-11-30 | |
| US201662351674P | 2016-06-17 | 2016-06-17 | |
| PCT/US2016/064227 WO2017095932A1 (en) | 2015-11-30 | 2016-11-30 | Steviol glycoside compositions for oral ingestion or use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201804542YA true SG11201804542YA (en) | 2018-06-28 |
Family
ID=58798108
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG10202004988YA SG10202004988YA (en) | 2015-11-30 | 2016-11-30 | Steviol glycoside compositions for oral ingestion or use |
| SG11201804542YA SG11201804542YA (en) | 2015-11-30 | 2016-11-30 | Steviol glycoside compositions for oral ingestion or use |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG10202004988YA SG10202004988YA (en) | 2015-11-30 | 2016-11-30 | Steviol glycoside compositions for oral ingestion or use |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US20200305481A1 (en) |
| EP (2) | EP3383201B1 (en) |
| JP (1) | JP6998884B2 (en) |
| KR (1) | KR20180081808A (en) |
| CN (1) | CN108289489B (en) |
| AU (2) | AU2016364725A1 (en) |
| BR (1) | BR112018010961B1 (en) |
| CA (1) | CA3005993A1 (en) |
| MY (1) | MY190650A (en) |
| SG (2) | SG10202004988YA (en) |
| WO (1) | WO2017095932A1 (en) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6855376B2 (en) | 2014-12-17 | 2021-04-07 | カーギル インコーポレイテッド | Steviol glycoside compounds, compositions for oral ingestion or use, and methods for enhancing steviol glycoside solubility. |
| SG11201705606PA (en) | 2015-01-30 | 2017-08-30 | Evolva Sa | Production of steviol glycosides in recombinant hosts |
| EP3718417A1 (en) | 2015-04-03 | 2020-10-07 | DSM IP Assets B.V. | Steviol glycosides |
| CA3027697C (en) * | 2016-06-17 | 2024-02-20 | Cargill, Incorporated | Steviol glycoside compositions for oral ingestion or use |
| MX2019004368A (en) * | 2016-10-14 | 2019-08-12 | Conagen Inc | Biosynthetic production of steviol glycosides and processes therefore. |
| US20200260767A1 (en) | 2017-10-06 | 2020-08-20 | Cargill, Incorporated | Readily dissolvable steviol glycoside compositions |
| MX2020009626A (en) * | 2018-03-16 | 2021-05-27 | Purecircle Usa Inc | High-purity steviol glycosides. |
| CN112367854A (en) * | 2018-06-08 | 2021-02-12 | 谱赛科美国股份有限公司 | High purity steviol glycosides |
| CN112533489A (en) * | 2018-07-24 | 2021-03-19 | 帝斯曼知识产权资产管理有限公司 | Stevioside aggregates having a specific particle size distribution |
| CN113227111A (en) * | 2018-11-27 | 2021-08-06 | 谱赛科美国股份有限公司 | High purity steviol glycosides |
| KR20210129679A (en) * | 2019-02-15 | 2021-10-28 | 퓨어써클 유에스에이 잉크. | High Purity Steviol Glycoside |
| WO2020210118A1 (en) | 2019-04-06 | 2020-10-15 | Cargill, Incorporated | Sensory modifiers |
| AU2021353004A1 (en) | 2020-09-30 | 2023-04-13 | Nobell Foods, Inc. | Recombinant milk proteins and food compositions comprising the same |
| US10947552B1 (en) | 2020-09-30 | 2021-03-16 | Alpine Roads, Inc. | Recombinant fusion proteins for producing milk proteins in plants |
| US10894812B1 (en) | 2020-09-30 | 2021-01-19 | Alpine Roads, Inc. | Recombinant milk proteins |
| EP4115741A1 (en) * | 2021-11-16 | 2023-01-11 | Pompadour Ibérica S.A. | A beverage composition with controlled effervescence for infusion in a cold liquid |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6180157B1 (en) | 1999-02-18 | 2001-01-30 | The Nutrasweet Company | Process for preparing an N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester agglomerate |
| AU4028300A (en) | 1999-03-26 | 2000-10-16 | Nutrasweet Company, The | Particles of n-(n-(3,3-dimethylbutyl)-l-alpha-aspartyl)-l-phenylalanine 1-methylester |
| JP2001048727A (en) * | 1999-08-10 | 2001-02-20 | Nonogawa Shoji Kk | Solubilizer and solubilizing composition containing the same |
| AU2001238482A1 (en) | 2000-02-16 | 2001-08-27 | The Nutrasweet Company | Process for making granulated n-(n-(3,3-dimethylbutyl)-l-alpha-aspartyl)-l-phenylalanine 1-methyl ester |
| PL2350110T3 (en) * | 2008-10-03 | 2016-12-30 | New steviol glycosides | |
| JP6290624B2 (en) * | 2010-12-13 | 2018-03-07 | カーギル・インコーポレイテッド | Glycoside mixture |
| PL3009010T3 (en) * | 2011-12-19 | 2020-10-19 | Purecircle Sdn Bhd | Methods for purifying steviol glycosides |
| US9060537B2 (en) | 2012-03-26 | 2015-06-23 | Pepsico, Inc. | Method for enhancing rebaudioside D solubility in water |
| MX2015003684A (en) * | 2012-09-25 | 2015-06-15 | Cargill Inc | Stevioside blends. |
| EP2928321A1 (en) * | 2012-12-05 | 2015-10-14 | Evolva SA | Steviol glycoside compositions sensory properties |
| US20140171519A1 (en) | 2012-12-19 | 2014-06-19 | Indra Prakash | Compositions and methods for improving rebaudioside x solubility |
| MX369525B (en) | 2013-02-06 | 2019-11-11 | Evolva Sa | Methods for improved production of rebaudioside d and rebaudioside m. |
| US20140342043A1 (en) * | 2013-05-14 | 2014-11-20 | Pepsico, Inc. | Rebaudioside Sweetener Compositions and Food Products Sweetened with Same |
| SG11201705606PA (en) * | 2015-01-30 | 2017-08-30 | Evolva Sa | Production of steviol glycosides in recombinant hosts |
-
2016
- 2016-11-30 CA CA3005993A patent/CA3005993A1/en active Pending
- 2016-11-30 EP EP16871428.5A patent/EP3383201B1/en active Active
- 2016-11-30 KR KR1020187017334A patent/KR20180081808A/en unknown
- 2016-11-30 JP JP2018547868A patent/JP6998884B2/en active Active
- 2016-11-30 SG SG10202004988YA patent/SG10202004988YA/en unknown
- 2016-11-30 BR BR112018010961-4A patent/BR112018010961B1/en active IP Right Grant
- 2016-11-30 SG SG11201804542YA patent/SG11201804542YA/en unknown
- 2016-11-30 AU AU2016364725A patent/AU2016364725A1/en not_active Abandoned
- 2016-11-30 EP EP22201856.6A patent/EP4159050A1/en active Pending
- 2016-11-30 US US15/779,761 patent/US20200305481A1/en not_active Abandoned
- 2016-11-30 WO PCT/US2016/064227 patent/WO2017095932A1/en active Application Filing
- 2016-11-30 MY MYPI2018702055A patent/MY190650A/en unknown
- 2016-11-30 CN CN201680070048.7A patent/CN108289489B/en active Active
-
2021
- 2021-06-10 AU AU2021203844A patent/AU2021203844B2/en active Active
-
2022
- 2022-03-28 US US17/705,802 patent/US20220295848A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP3383201B1 (en) | 2022-11-30 |
| WO2017095932A1 (en) | 2017-06-08 |
| SG10202004988YA (en) | 2020-07-29 |
| CN108289489B (en) | 2022-09-16 |
| JP2018535702A (en) | 2018-12-06 |
| EP3383201A4 (en) | 2019-06-05 |
| EP4159050A1 (en) | 2023-04-05 |
| CN108289489A (en) | 2018-07-17 |
| BR112018010961B1 (en) | 2022-12-27 |
| AU2016364725A1 (en) | 2018-06-14 |
| MY190650A (en) | 2022-04-30 |
| CA3005993A1 (en) | 2017-06-08 |
| AU2021203844A1 (en) | 2021-07-08 |
| JP6998884B2 (en) | 2022-01-18 |
| AU2021203844B2 (en) | 2023-06-01 |
| US20200305481A1 (en) | 2020-10-01 |
| KR20180081808A (en) | 2018-07-17 |
| US20220295848A1 (en) | 2022-09-22 |
| BR112018010961A2 (en) | 2018-12-04 |
| EP3383201A1 (en) | 2018-10-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11201804542YA (en) | Steviol glycoside compositions for oral ingestion or use | |
| SG11201811273RA (en) | Steviol glycoside compositions for oral ingestion or use | |
| SG11201901126UA (en) | Combination therapy for cancer | |
| SG11201908367TA (en) | Flavor modifiers for meat analog products | |
| SG11201805300QA (en) | Heterocyclic compounds as immunomodulators | |
| SG11201811432WA (en) | Rna for cancer therapy | |
| SG11201808679WA (en) | A synthetic zeolite comprising a catalytic metal | |
| SG11201810034XA (en) | ANTI-cMet ANTIBODY DRUG CONJUGATES AND METHODS FOR THEIR USE | |
| SG11201811431VA (en) | Multispecific antibodies against cd40 and cd137 | |
| SG11201907744QA (en) | Replacement of cytotoxic preconditioning before cellular immunotherapy | |
| SG11201907034PA (en) | Methods of treating influenza | |
| SG11201908919XA (en) | Combination therapies targeting pd-1, tim-3, and lag-3 | |
| SG11201408605UA (en) | Methods for biodegradable derivatization of cellulosic surfaces | |
| SG11201804577RA (en) | Fgf21 variants | |
| SG11201907604UA (en) | Crystalline forms of the 4-pyrimidinesulfamide derivative aprocitentan | |
| SG11201909155VA (en) | Ask1 inhibitor compounds and uses thereof | |
| SG11201810101TA (en) | A system and method for ultrasound-enhanced delivery of drugs | |
| SG11201809908TA (en) | Stabilized glycopeptide antibiotic formulations | |
| SG11201909837YA (en) | Methods for treating lung disorders | |
| SG11201908325PA (en) | Process for the preparation of glucuronide drug-linkers and intermediates thereof | |
| SG11201808713YA (en) | Ophthalmic compositions comprising levodopa, an antioxidant and an aqueous carrier | |
| SG11201803918VA (en) | Production of steviol glycosides in recombinant hosts | |
| SG11201407536UA (en) | Topical pharmaceutical compositions comprising terbinafine and urea | |
| SG11201901389XA (en) | Combination therapy with glutaminase inhibitors | |
| SG11201909872WA (en) | Stability of short path evaporation treated oils |